Lymphatic Mapping in Colon Cancer Depending on Injection Time and Tracing Agent: A Systematic Review and Meta-Analysis of Prospective Designed Studies
Open Access
Abstract
An optimized lymph node yield leads to better survival in colon cancer, but extended lymphadenectomy is not associated with survival benefits. Lymphatic mapping shows several colon cancers feature aberrant drainage pathways inducing local recurrence when not resected. Currently, different protocols exist for lymphatic mapping procedures. This meta-analysis assessed which protocol has the best capacity to detect tumor-draining and possibly metastatic lymph nodes. A systematic review was conducted according to PRISMA guidelines, including prospective trials with in vivo tracer application. The risk of bias was evaluated using the QUADAS-2 tool. Traced lymph nodes, total resected lymph nodes, and aberrant drainage detection rate were analyzed. Fifty-eight studies met the inclusion criteria, of which 42 searched for aberrant drainage. While a preoperative tracer injection significantly increased the traced lymph node rates compared to intraoperative tracing (30.1% (15.4, 47.3) vs. 14.1% (11.9, 16.5), p = 0.03), no effect was shown for the tracer used (p = 0.740) or the application sites comparing submucosal and subserosal injection (22.9% (14.1, 33.1) vs. 14.3% (12.1, 16.8), p = 0.07). Preoperative tracer injection resulted in a significantly higher rate of detected aberrant lymph nodes compared to intraoperative injection (26.3% [95% CI 11.5, 44.0] vs. 2.5% [95% CI 0.8, 4.7], p < 0.001). Analyzing 112 individual patient datasets from eight studies revealed a significant impact on aberrant drainage detection for injection timing, favoring preoperative over intraoperative injection (OR 0.050 [95% CI 0.010–0.176], p < 0.001) while indocyanine green presented itself as the superior tracer (OR 0.127 [95% CI 0.018–0.528], p = 0.012). Optimized lymphatic mapping techniques result in significantly higher detection of aberrant lymphatic drainage patterns and thus enable a personalized approach to reducing local recurrence.Keywords
Funding Information
- Fritz Thyssen Stiftung (2022-00755)
This publication has 185 references indexed in Scilit:
- Lymph road mapping obtained via blue sentinel node detection to avoid middle colic artery resection for highly selected colon cancer cases: proof of a concept?Techniques in Coloproctology, 2010
- The sentinel node procedure in colon carcinoma: a multi-centre study in The NetherlandsInternational Journal of Colorectal Disease, 2007
- Laparoscopic lymphatic mapping and sentinel lymph node detection in colon cancer: technical aspects and preliminary resultsSurgical Endoscopy, 2007
- A multicenter trial of sentinel lymph node mapping in colorectal cancer: prognostic implications for nodal staging and recurrenceThe American Journal of Surgery, 2006
- 1% Lymphazurin vs 10% Fluorescein for Sentinel Node Mapping in Colorectal TumorsArchives of Surgery, 2004
- Successful sentinel node identification in colon carcinoma using Patent Blue VEuropean Journal of Surgical Oncology, 2004
- Identification of Sentinel Lymph Nodes in Colon Cancer Depends on the Amount of Dye Injected Relative to Tumor SizeWorld Journal of Surgery, 2003
- Intraoperative sentinel lymph node mapping in patients with colon cancerThe American Journal of Surgery, 2001
- Lymphatic mapping improves staging during laparoscopic colectomy for cancerSurgical Endoscopy, 2001
- Validation of Lymphatic Mapping in Colorectal Cancer: In Vivo, Ex Vivo, and Laparoscopic TechniquesAnnals of Surgical Oncology, 2001